`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`
`
`
`
`
`
`
`
`
`
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`
`
`
`
`
`
`
`
`
`
`
`APOTEX CORP.
`APOTEX, INC.
`Petitioner
`
`v.
`
`ALLERGAN, INC.
`Patent Owner
`
`
`
`
`
`
`
`
`
`
`
`
`Case IPR2015-01278
`Patent 8, 633,162
`
`
`
`
`
`
`
`
`
`
`
`
`PATENT OWNER ALLERGAN, INC.’S
`MANDATORY NOTICES
`
`
`
`Case IPR2015-01278
`Attorney Docket No: 13351-0035IP1
`
`
`
`
`
`PATENT OWNER’S MANDATORY NOTICES
`UNDER 37 C.F.R. § 42.8
`
`Pursuant to 37 C.F.R. § 42.8, the patent owner, Allergan, Inc. (“Patent
`
`Owner”), hereby submits the following Mandatory Notices in response to the
`
`Petition for Inter Partes Review of U.S. Patent No. 8,633,162.
`
`1.
`
`Real Party-In-Interest under 37 CFR § 42.8(b)(1)
`
`Allergan, Inc. is the Patent Owner and the Real Party-In-Interest in this
`
`proceeding.
`
`2.
`
`Related Matters under 37 CFR § 42.8(b)(2)
`
`The following patents and pending patent applications are related to U.S.
`
`Patent No. 8,633,162: 13/961,818 filed on 08-07-2013; 8,618,064 issued on 12-
`
`31-2013; 10/927,857 filed on 08-27-2004; and 60/503,137 filed on 09-15-2003.
`
`The following judicial or administrative matters may affect or be affected by
`
`a decision in this proceeding: Allergan, Inc., v. Actavis, Inc. et al., No. 22:14-CV-
`
`638 (D. Texas) and Allergan, Inc. v. Actavis, Inc. et al., No. 2:14-CV-188 (D.
`
`Texas).
`
`3.
`
`Lead and Back-Up Counsel, under 37 CFR § 42.8(b)(3)
`
`The Patent Owner designates the following lead and back-up counsel:
`
`LEAD COUNSEL
`Dorothy P. Whelan, Reg. No. 33,814
`3200 RBC Plaza
`60 South Sixth Street
`
`BACK-UP COUNSEL
`Michael Kane, Reg. No. 39,722
`3200 RBC Plaza
`60 South Sixth Street
`
`2
`
`
`
`Minneapolis, MN 55402
`Tel: (612) 337-2509
`Email:
`whelan@fr.com
`Fax:
`
`(612) 288-9696
`
`4.
`
`Service Information under 37 CFR § 42.8(b)(4)(i) et seq.
`
`Case IPR2015-01278
`Attorney Docket No: 13351-0035IP1
`Minneapolis, MN 55402
`Tel: (612) 337-2502
`Email: IPR13351-0035IP1@fr.com
`Fax:
` (612) 288-9696
`
`Please address all correspondence and service to both counsel as listed
`
`above. Patent Owner consents to service by email at IPR13351-0035IP1@fr.com
`
`(ref.: Docket No. IPR13351-0035IP1).
`
`
`
`
`
`Date:/June 15, 2015/
`
`
`Customer Number 26191
`Fish & Richardson P.C.
`Telephone: (612) 337-2508
`Facsimile: (612) 288-9696
`
`
`
`
`
`
`
`Respectfully submitted,
`
`/Dorothy P. Whelan/
`Dorothy P. Whelan
`Reg. No. 33,814
`
`
`
`3
`
`
`
`Case IPR2015-01278
`Attorney Docket No: 13351-0035IP1
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 CFR §§ 42.6(e)(4) and 42.205(b), the undersigned certifies
`
`that on June 15, 2015, a complete and entire copy of this Patent Owner Allergan,
`
`Inc.’s Mandatory Notices and Power of Attorney were provided via electronic
`
`service, to the Petitioner by serving the correspondence address of record as
`
`follows:
`
`Eldora L. Ellison
`Ralph W. Powers III
`Sterne, Kessler, Goldstein & Fox P.L.L.C.
`1100 New York Avenue, NW
`Washington, DC 20005
`eellison-PTAB@skgf.com
`tpowers-PTAB@skgf.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /Jessica K. Detko/
`
`Jessica K. Detko
`Fish & Richardson P.C.
`60 South Sixth Street, Suite 3200
`Minneapolis, MN 55402
`(612) 337-2516
`
`4
`
`